Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |